Erratum: Incidence, prevalence, and temporal trends of microscopic colitis: A systematic review and meta-analysis (Am J Gastroenterol 110:265-276(2015) DOI: 10.1038/ajg.2014.431);Incidence, prevalence, and temporal trends of microscopic colitis: A systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 110, Issue 2, 2015, Pages 265-276

  Tong, Jinlu ^a   Zheng, Qinq ^a   Zhang, Chenpeng ^a   Lo, Ryan ^b   Shen, Jun ^a   Ran, Zhihua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AGE; CANADA; COLLAGENOUS COLITIS; DENMARK; EMBASE; FRANCE; HUMAN; ICELAND; INCIDENCE; MEDLINE; META ANALYSIS; MICROSCOPIC COLITIS; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX RATIO; SPAIN; SWEDEN; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; WEB OF SCIENCE; AGED; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, MICROSCOPIC; FEMALE; MALE; MIDDLE AGED; ONSET AGE; POPULATION GROWTH; RISK FACTOR;

AGE OF ONSET; AGED; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, MICROSCOPIC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION GROWTH; PREVALENCE; PROTON PUMP INHIBITORS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SEX DISTRIBUTION; SPAIN; SWEDEN; UNITED STATES;

EID: 84922185462     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.46     Document Type: Erratum

References (39)

1. Munch A, Aust D, Bohr J et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6: 932-45.
2. Bohr J, Tysk C, Eriksson S et al. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut 1995; 37: 394-7.
3. Fernandez-Banares F, Salas A, Forne M et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999; 94: 418-23.
4. Agnarsdottir M, Gunnlaugsson O, Orvar KB et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002; 47: 1122-8.
5. Olesen M, Eriksson S, Bohr J et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 2004; 53: 346-50.
6. Pardi DS, Loft us EV Jr, Smyrk TC et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504-8.
7. Wigh T, Fenger-Gron M, Nielsen GL et al. Epidemiology of microscopic colitis-a 10-year nationwide Danish Cohort Study. Gastroenterology 2013; 144: S645-S645.
8. Verhaegh BP, Jonkers DM, Driessen A et al. Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000-2012. Dig Liver Dis 2015; 47: 30-6.
9. Gentile NM, Khanna S, Loftus EV Jr et al. The epidemiology of microscopic colitis in olmsted county from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol 2014; 12: 838-42.
10. Vigren L, Olesen M, Benoni C et al. An epidemiological study of collagenous colitis in southern Sweden from 2001-2010. World J Gastroenterol 2012; 18: 2821-6.
11. Nyhlin N, Bohr J, Eriksson S et al. Systematic review: microscopic colitis. Aliment Pharmacol Ther 2006; 23: 1525-34.
12. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther 2012; 36: 79-90.
13. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
14. Loney PL, Chambers LW, Bennett KJ et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998; 19: 170-6.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
16. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54 e42; quiz e30.
17. Williams JJ, Kaplan GG, Makhija S et al. Microscopic colitis-defi ning incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 35-40.
18. Fernandez-Banares F, Salas A, Esteve M et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a populationbased study. Infl amm Bowel Dis 2011; 17: 1015-20.
19. Stewart M, Andrews CN, Urbanski S et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 2011; 33: 1340-9.
20. Bjornbak C, Engel PJ, Nielsen PL et al. Microscopic colitis: clinical fi ndings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011; 34: 1225-34.
21. Guagnozzi D, Lucendo AJ, Angueira-Lapena T et al. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis 2012; 44: 384-8.
22. Wickbom A, Bohr J, Eriksson S et al. Stable incidence of collagenous colitis and lymphocytic colitis in Orebro, Sweden, 1999-2008: a continuous epidemiologic study. Infl amm Bowel Dis 2013; 19: 2387-93.
23. Thorn M, Sjoberg D, Ekbom A et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005-2009. Scand J Gastroenterol 2013; 48: 825-30.
24. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-infl ammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992; 33: 683-6.
25. Fernandez-Banares F, Esteve M, Espinos JC et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007; 102: 324-30.
26. Keszthelyi D, Jansen SV, Schouten GA et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther 2010; 32: 1124-8.
27. Pascua MF, Kedia P, Weiner MG et al. Microscopic colitis and medication use. Clin Med Insights Gastroenterol 2010; 2010: 11-19.
28. Fernandez-Banares F, de Sousa MR, Salas A et al. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Infl amm Bowel Dis 2013; 19: 411-7.
29. Bonderup OK, Fenger-Gron M, Wigh T et al. Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. Infl amm Bowel Dis 2014; 20: 1702-7.
30. Raclot G, Queneau PE, Ottignon Y et al. Incidence of collagenous colitis-a retrospective study in the east of France. Gastroenterology 1994; 106: A23-A23.
31. Heron T, Walsh S, Mowat C. Microscopic colitis in tayside: clinical features, associations, and behaviour. Gut 2005; 54: A84-A84.
32. Rajan JN, Noble C, Anderson C et al. The epidemiology and clinical features of collagenous colitis in Lothian. Gut 2005; 54: A99-A100.
33. Ianiro G, Cammarota G, Valerio L et al. Microscopic colitis. World J Gastroenterol 2012; 18: 6206-15.
34. Garg PK, Singh J, Dhali GK et al. Microscopic colitis is a cause of large bowel diarrhea in Northern India. J Clin Gastroenterol 1996; 22: 11-15.
35. Rubio-Tapia A, Martinez-Salgado J, Garcia-Leiva J et al. Microscopic colitides: a single center experience in Mexico. Int J Colorectal Dis 2007; 22: 1031-6.
36. Park YS, Baek DH, Kim WH et al. Clinical characteristics of microscopic colitis in Korea: prospective multicenter study by KASID. Gut Liver 2011; 5: 181-6.
37. United Nations, Department of Economic and Social Aff airs, Population Division (2013). World Population Ageing 2013. ST/ESA/SER. A/348.
38. Holstein A, Burmeister J, Plaschke A et al. Autoantibody profi les in microscopic colitis. J Gastroenterol Hepatol 2006; 21: 1016-20.
39. Keszthelyi D, Penders J, Masclee AA et al. Is microscopic colitis a druginduced disease? J Clin Gastroenterol 2012; 46: 811-22.